AstraZeneca CEO Brennan Talks About Cutting Deals and Dealing With Change

PhRMA's new chairman, AstraZeneca CEO David Brennan, wants to make a deal on health reform - but not necessarily the kind of tradeoff the industry made on the Medicare drug benefit